EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study

Saman Ahmad Nasrollahi iD, Mahsa Fattahi iD, Ensieh Lotfali iD, Atefeh Naeimifar iD, Fatemeh Amiri iD, Aliasghar Ghaderi iD, Pegah Tamimi iD, Shayan Zamani iD, Ali Khamesipoor, Alireza Firooz iD

Dermatology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/drp/5995621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Research and Practice, online erschienen am 21.04.2026. Verfasst von Saman Ahmad Nasrollahi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There have been several reports of patients with chronic recalcitrant diseases, rare presentations, recurrent relapses, and treatment failure. This study aimed to formulate and evaluate the safety profile of topical voriconazole (VCZ) gel 0.25% for effective drug delivery to the skin as an adjuvant therapy in cases of extensive dermatophytosis. Methods and Materials VCZ 0.25% topical gel was manufactured by Carbomer, and its characteristics such as pH, viscosity, density, and microbial growth were examined at 40 ± 2°C/75 ± 5% RH for six months. The animals were divided into three groups (2:2:2) randomly. The hair from the back of guinea pigs (test sites: 2 cm 2 ) was shaven, and their skin was scraped slightly using a single‐use scalpel. Afterward, terbinafine drug–resistant Arthroderma benhamiae suspension (50 μL) was inoculated to a 2 cm 2 surface area of the shaven skin.

Results

Agar culture of scrapings from the area indicated the infection development. The fabricated VCZ topical gel exhibited acceptable stability. The VCZ 0.25% gel was proved to be an effective treatment in a time‐dependent base, in comparison with terbinafine (1%) as a positive control ( p < 0.05). Furthermore, using gel base VCZ 0.25% reduced the period of full treatment of A. benhamiae infection to five days, compared with the 12‐day complete cure by terbinafine.

Conclusion

Results from the present study indicated that gel‐based VCZ could be utilized as topical therapy for dermatophytosis. Due to the increase of drug‐resistant dermatophyte spp., indications of gel base VCZ 0.25% for treating dermatophytosis are believed to increase accordingly.

Schlagwörter

Stichwörter der Autor:innen

antifungal treatmentsevere dermatophytosistopical deliveryvoriconazole gel 0.25%

Autor:innen und Institutionen

  • Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
  • Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
  • Children's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
  • Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.
  • Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.

ORCID-Profile: Saman Ahmad Nasrollahi, Mahsa Fattahi, Ensieh Lotfali, Atefeh Naeimifar, Fatemeh Amiri, Aliasghar Ghaderi, Pegah Tamimi, Shayan Zamani, Alireza Firooz

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Nasrollahi, S. A., Fattahi, M., Lotfali, E., Naeimifar, A., Amiri, F., Ghaderi, A., Tamimi, P., Zamani, S., Khamesipoor, A., & Firooz, A. (2026). Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study. Dermatology Research and Practice, 2026(1). https://doi.org/10.1155/drp/5995621

Vancouver

Nasrollahi SA, Fattahi M, Lotfali E, Naeimifar A, Amiri F, Ghaderi A, et al. Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study. Dermatology Research and Practice. 2026;2026(1). doi:10.1155/drp/5995621

BibTeX
@article{Nasrollahi2026,
  author = {Nasrollahi, Saman Ahmad and Fattahi, Mahsa and Lotfali, Ensieh and Naeimifar, Atefeh and Amiri, Fatemeh and Ghaderi, Aliasghar and Tamimi, Pegah and Zamani, Shayan and Khamesipoor, Ali and Firooz, Alireza},
  title = {Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study},
  journal = {Dermatology Research and Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/drp/5995621}
}
Kostenlos starten →